Correlation Between Neogen and Myriad Genetics
Can any of the company-specific risk be diversified away by investing in both Neogen and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neogen and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neogen and Myriad Genetics, you can compare the effects of market volatilities on Neogen and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neogen with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neogen and Myriad Genetics.
Diversification Opportunities for Neogen and Myriad Genetics
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Neogen and Myriad is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Neogen and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and Neogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neogen are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of Neogen i.e., Neogen and Myriad Genetics go up and down completely randomly.
Pair Corralation between Neogen and Myriad Genetics
Given the investment horizon of 90 days Neogen is expected to generate 1.12 times more return on investment than Myriad Genetics. However, Neogen is 1.12 times more volatile than Myriad Genetics. It trades about -0.08 of its potential returns per unit of risk. Myriad Genetics is currently generating about -0.21 per unit of risk. If you would invest 1,212 in Neogen on October 23, 2024 and sell it today you would lose (56.00) from holding Neogen or give up 4.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neogen vs. Myriad Genetics
Performance |
| Timeline |
| Neogen |
| Myriad Genetics |
Neogen and Myriad Genetics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neogen and Myriad Genetics
The main advantage of trading using opposite Neogen and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neogen position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.| Neogen vs. Qiagen NV | Neogen vs. Aclaris Therapeutics | Neogen vs. IQVIA Holdings | Neogen vs. Medpace Holdings |
| Myriad Genetics vs. Guardant Health | Myriad Genetics vs. Caredx Inc | Myriad Genetics vs. Castle Biosciences | Myriad Genetics vs. Sotera Health Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |